BG103133A - New erythromycins and method for their preparation - Google Patents

New erythromycins and method for their preparation

Info

Publication number
BG103133A
BG103133A BG103133A BG10313399A BG103133A BG 103133 A BG103133 A BG 103133A BG 103133 A BG103133 A BG 103133A BG 10313399 A BG10313399 A BG 10313399A BG 103133 A BG103133 A BG 103133A
Authority
BG
Bulgaria
Prior art keywords
preparation
erythromycins
new
new erythromycins
r1co2h
Prior art date
Application number
BG103133A
Other languages
Bulgarian (bg)
English (en)
Inventor
Peter LEADLAY
James Staunton
Jesus Cortes
Michael PACEY
Original Assignee
Pfizer Inc.
Biotica Technology Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614189.0A external-priority patent/GB9614189D0/en
Priority claimed from GBGB9710962.3A external-priority patent/GB9710962D0/en
Application filed by Pfizer Inc., Biotica Technology Limited filed Critical Pfizer Inc.
Publication of BG103133A publication Critical patent/BG103133A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BG103133A 1996-07-05 1999-01-29 New erythromycins and method for their preparation BG103133A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9614189.0A GB9614189D0 (en) 1996-07-05 1996-07-05 Polyketides and their synthesis
US2418896P 1996-08-19 1996-08-19
GBGB9710962.3A GB9710962D0 (en) 1997-05-28 1997-05-28 Polyketides and their synthesis
PCT/GB1997/001810 WO1998001571A2 (en) 1996-07-05 1997-07-04 Erythromycins and process for their preparation

Publications (1)

Publication Number Publication Date
BG103133A true BG103133A (en) 2000-04-28

Family

ID=27268361

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103133A BG103133A (en) 1996-07-05 1999-01-29 New erythromycins and method for their preparation

Country Status (28)

Country Link
EP (3) EP2182067A3 (is)
JP (2) JP2000511063A (is)
KR (1) KR20000023579A (is)
CN (1) CN1179046C (is)
AP (1) AP1029A (is)
AT (2) ATE451455T1 (is)
AU (2) AU731301B2 (is)
BG (1) BG103133A (is)
BR (1) BR9710209A (is)
CA (2) CA2259463A1 (is)
DE (2) DE69739688D1 (is)
DK (2) DK0909327T3 (is)
EA (1) EA001744B1 (is)
EE (1) EE03976B1 (is)
ES (2) ES2337424T3 (is)
GB (1) GB2331518B (is)
GE (1) GEP20012348B (is)
IL (1) IL127916A0 (is)
IS (1) IS4940A (is)
NO (1) NO990012L (is)
NZ (1) NZ333861A (is)
OA (1) OA10952A (is)
PL (1) PL331285A1 (is)
PT (1) PT909327E (is)
SI (1) SI0910633T1 (is)
SK (1) SK182498A3 (is)
TR (1) TR199900006T2 (is)
WO (2) WO1998001546A2 (is)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063561A (en) * 1991-01-17 2000-05-16 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US6500960B1 (en) 1995-07-06 2002-12-31 Stanford University (Board Of Trustees Of The Leland Stanford Junior University) Method to produce novel polyketides
WO1998049315A2 (en) 1997-04-30 1998-11-05 Kosan Biosciences, Inc. Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
US20030170725A1 (en) 1993-09-20 2003-09-11 Chaitan Khosla Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
US6927057B2 (en) 1993-09-20 2005-08-09 Kosan Biosciences Macrolide analogs
US6558942B1 (en) 1994-05-06 2003-05-06 The Leland Stanford Junior University Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
IL122859A0 (en) 1995-07-06 1998-08-16 Univ Leland Stanford Junior Cell-free synthesis of polyketides
EP0870053A4 (en) 1995-12-19 2002-09-11 Univ Minnesota METABOLIC METHOD FOR PRODUCING POLYHYDROXYALKANOATE MONOMER SYNTHASES
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US6399789B1 (en) 1996-12-18 2002-06-04 Kosan Biosciences, Inc. Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
US6902913B2 (en) 1997-04-30 2005-06-07 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
US6117659A (en) * 1997-04-30 2000-09-12 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
JP2008169226A (ja) * 1997-04-30 2008-07-24 Kosan Biosciences Inc 足場としてモジュラー性pks遺伝子クラスターを使用して生成されるコンビナトリアルなポリケチドライブラリー
US6503741B1 (en) 1998-05-28 2003-01-07 Kosan Biosciences, Inc. Polyketide synthase genes from Streptomyces venezuelae
US6262340B1 (en) 1997-07-10 2001-07-17 Kosan Biosciences, Inc. Production of polyketides in plants
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AU2066799A (en) * 1998-01-14 1999-08-02 Glaxo Group Limited Polyketides and their synthesis
NZ509006A (en) * 1998-05-28 2003-09-26 Kosan Biosciences Inc Recombinant narbonolide polyketide synthase
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
GB9814006D0 (en) * 1998-06-29 1998-08-26 Biotica Tech Ltd Polyketides and their synthesis
EP1100927A2 (en) * 1998-07-02 2001-05-23 The Board Of Trustees Of The Leland Stanford Junior University Methods for making polyketides using altered pks
GB9814622D0 (en) * 1998-07-06 1998-09-02 Biotica Tech Ltd Polyketides,their preparation,and materials for use therein
WO2000024907A2 (en) 1998-10-28 2000-05-04 Kosan Biosciences, Inc. Library of novel "unnatural" natural products
KR20010083944A (ko) 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
US6358712B1 (en) 1999-01-05 2002-03-19 Trustee Of Boston University Ordered gene assembly
WO2000040715A2 (en) 1999-01-05 2000-07-13 Trustees Of Boston University Improved nucleic acid cloning
CA2359708C (en) 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
US7001748B2 (en) 1999-02-09 2006-02-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of making polyketides using hybrid polyketide synthases
CA2359801A1 (en) * 1999-02-09 2000-08-17 Rajesh S. Gokhale Methods to mediate polyketide synthase module effectiveness
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
ID30547A (id) 1999-04-16 2001-12-20 Kosan Biosciences Inc Zat anti-infeksi makrolida
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
GB9912563D0 (en) * 1999-05-28 1999-07-28 Biotica Tech Ltd Polyketides and their synthesis
WO2001034816A1 (en) * 1999-10-29 2001-05-17 Kosan Biosciences, Inc. Rapamycin analogs
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
CA2399198A1 (en) 2000-02-18 2001-08-23 Christopher Carreras Motilide compounds
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
ATE453719T1 (de) 2000-04-13 2010-01-15 Biotica Tech Ltd Glycosylierte hybrid-verbindungen, deren herstellung und verwendung
MXPA04008071A (es) * 2002-02-19 2004-11-26 Dow Agrosciences Llc Nuevas sintasas de poliquetida que producen espinosina.
CA2492153C (en) 2002-07-16 2012-05-08 Biotica Technology Limited Production of polyketide fkbp-ligand analogues
DK200201957A (da) * 2002-12-20 2003-01-20 Alpharma Aps 10-substituted erythromycin ketolides and methods of making
GB0230217D0 (en) * 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
US7476403B2 (en) 2003-06-16 2009-01-13 Andrx Pharmaceuticals, Llc Oral extended-release composition
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
EP2342335B1 (en) 2008-09-24 2015-09-16 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Novel gene cluster
GB0904540D0 (en) 2009-03-17 2009-04-29 Biotica Tech Ltd Novel compounds and methods for their production
GB0914589D0 (en) 2009-08-20 2009-09-30 Biotica Tech Ltd Novel compounds and methods for their production
AU2011214135B2 (en) 2010-02-09 2014-07-31 Neurovive Pharmaceutical Ab Sanglifehrin based compounds
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
GB201118334D0 (en) 2011-10-24 2011-12-07 Biotica Tech Ltd Novel dosage form
WO2013172782A1 (en) * 2012-05-16 2013-11-21 Nanyang Technological University A polyketide synthase construct and its use in the preparation of polyketides
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
CA3020594A1 (en) 2016-04-12 2017-10-19 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
WO2018020272A1 (en) 2016-07-29 2018-02-01 Isomerase Therapeutics Limited Novel methods
KR102561694B1 (ko) * 2016-10-28 2023-07-28 징코 바이오웍스, 인크. 화합물의 생산을 위한 조성물 및 방법
JP2020501519A (ja) 2016-10-28 2020-01-23 ギンゴー バイオワークス, インコーポレイテッド 化合物の生産のための組成物および方法
JP7100652B2 (ja) 2017-02-22 2022-07-13 アイエスアール イミューン システム レギュレイション ホールディング アクチエボラグ(パブル) 新規免疫刺激マクロライド
EP3585796B1 (en) 2017-02-22 2021-06-16 ISR Immune System Regulation Holding AB (publ) Novel immune stimulating macrolides
JP2021523930A (ja) 2018-03-23 2021-09-09 アイエスアール イミューン システム レギュレイション ホールディング アクチエボラグ(パブル) マクロライド化合物と免疫チェックポイント阻害剤との組み合わせ
EP3914245A4 (en) 2019-01-22 2022-08-24 Aeovian Pharmaceuticals, Inc. MTORC-1 MODULATORS AND USES THEREOF
CN120699039A (zh) 2019-11-04 2025-09-26 锐新医药公司 Ras抑制剂
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
MX2023003060A (es) 2020-09-15 2023-04-05 Revolution Medicines Inc Derivados indolicos como inhibidores de ras en el tratamiento del cancer.
AU2022268962A1 (en) 2021-05-05 2023-12-14 Revolution Medicines, Inc. Ras inhibitors for the treatment of cancer
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
KR102775118B1 (ko) 2022-07-26 2025-02-27 강원대학교산학협력단 에리트로마이신으로 로딩된 키토산 결합 닭뼈유래 수산화인회석 나노입자 및 그 제조방법
CN117288869B (zh) * 2023-11-24 2024-02-09 中国医学科学院医药生物技术研究所 一种原料药中对甲苯磺酸酯类杂质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5712146A (en) * 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
ES2164713T3 (es) * 1993-09-20 2002-03-01 Univ Leland Stanford Junior Produccion recombinante de nuevos poliquetidos.

Also Published As

Publication number Publication date
ES2337424T3 (es) 2010-04-23
EA001744B1 (ru) 2001-08-27
JP4173551B2 (ja) 2008-10-29
DE69733416T2 (de) 2006-04-27
AU731301B2 (en) 2001-03-29
PL331285A1 (en) 1999-07-05
EE03976B1 (et) 2003-02-17
EA199900087A1 (ru) 1999-08-26
WO1998001571A3 (en) 1998-02-19
AP9901444A0 (en) 1999-03-31
CN1179046C (zh) 2004-12-08
EP2182067A2 (en) 2010-05-05
WO1998001546A3 (en) 1998-04-09
AU731654B2 (en) 2001-04-05
GB2331518A (en) 1999-05-26
GEP20012348B (en) 2001-01-25
PT909327E (pt) 2005-10-31
EE9900014A (et) 1999-08-16
DE69739688D1 (de) 2010-01-21
SI0910633T1 (sl) 2010-04-30
EP0910633B1 (en) 2009-12-09
ATE296893T1 (de) 2005-06-15
AP1029A (en) 2001-12-11
NO990012D0 (no) 1999-01-04
GB2331518B (en) 2001-03-14
DK0910633T3 (da) 2010-03-29
EP0909327A2 (en) 1999-04-21
IS4940A (is) 1999-01-04
SK182498A3 (en) 2000-05-16
TR199900006T2 (xx) 1999-04-21
CA2259420A1 (en) 1998-01-15
AU3450997A (en) 1998-02-02
DE69733416D1 (de) 2005-07-07
ES2244001T3 (es) 2005-12-01
IL127916A0 (en) 1999-11-30
NZ333861A (en) 2000-08-25
EP2182067A3 (en) 2010-07-14
CA2259420C (en) 2007-09-18
JP2000511063A (ja) 2000-08-29
AU3451497A (en) 1998-02-02
DK0909327T3 (da) 2005-09-26
EP0909327B1 (en) 2005-06-01
NO990012L (no) 1999-02-23
CN1229438A (zh) 1999-09-22
ATE451455T1 (de) 2009-12-15
WO1998001571A2 (en) 1998-01-15
JP2000516450A (ja) 2000-12-12
GB9900156D0 (en) 1999-02-24
BR9710209A (pt) 2000-01-11
EP0910633A2 (en) 1999-04-28
KR20000023579A (ko) 2000-04-25
WO1998001546A2 (en) 1998-01-15
OA10952A (en) 2002-02-25
CA2259463A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
BG103133A (en) New erythromycins and method for their preparation
PH31271A (en) 9-Deoxotaxane compounds.
TW233242B (is)
NZ263360A (en) Aza-cyclohexapeptide compounds and their use as antibiotic compounds
AU565019B2 (en) Cl-1557 antibiotic/antitumor compounds
EP0877081B8 (en) Microorganisms culture medium
AU4091297A (en) Antiparasitic agents
CA2152963A1 (en) A process for producing immunosuppressives and a novel microbial species to be employed therein
HU911893D0 (en) Process for producing derivatives of 'radicicol'
TW349124B (en) Osmotically controlled fermentation process for the preparation of acarbose
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
AU1192797A (en) Oxidase, microorganisms producing the same and use of the same
YU4999A (sh) Novi eritromicini i postupak njihovog dobijanja
HU901427D0 (en) Process for the preparation of ws7622 a, b, c and d
IL90575A0 (en) Ab-011 antibiotics,their production and compositions containing them
DE69209610D1 (de) Verfahren zur Herstellung des Antibiotikums A82810 aus Actinomadura fibrosa sp. no. NRRL 18348 und Actinomadura sp. NRRL 18880
GR3031236T3 (en) Process for the preparation of pilocarpine.
DE69121024D1 (de) Dns-segmente und das delta-1 des hydrogenasegen enthaltende mikroorganismen und ihre verwendung
ATE164881T1 (de) Mikroorganismen und verfahren zur herstellung von 3-alpha, 7-alpha-dihydroxy-12-keto-cholansäure
MX9601913A (es) Agentes fungicidas ll-15g256-gamma, ll-15g256-delta y ll-15g256-epsilon producidos por ll-15g256 (hypoxylon oceanicum).
ZA918160B (en) Novel avermectins are produced from known microorganisms
CA2156908A1 (en) C9 taxane derivatives and pharmaceutical compositions containing them
EP1602727A3 (en) Novel erythromycins and process for their preparation